9783540692966 - Cancer Prevention II: 181 (Recent Results in Cancer Research, 181) (16 resultados)

Condición: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.

Condición: Wie Neu. Zustandsbeschreibung: Einband leicht bestoßen. Edited by Hans-Jörg Senn, Ursula Kapp and Florian Otto. 251 Seiten, gebunden (Recent Results iin Cancer Research; Band 181/Springer-Verlag 2009). Statt EUR 123,00. Gewicht: 578 g - Gebunden/Gebundene Ausgabe.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: Sehr gut. Zustand: Sehr gut | Seiten: 272 | Sprache: Englisch | Produktart: Bücher | More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on ¿Primary Therapy of Early Breast Cancer¿ as well as ¿Supportive Care in Cancer¿ for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today¿s medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland¿and we fear in many other parts of the globe¿some 97%¿98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%¿3% of national health budgets is for preventive medicine, even less than that proportion is specifically allocated for cancer prevention. When the money for ¿curing and caring¿ for the diseased populace runs short, there is likely not much left for partly controversial disease prevention in the (still) healthy part of the population.

Condición: New. In.

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on 'Primary Therapy of Early Breast Cancer' as well as 'Supportive Care in Cancer' for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today's medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland-and we fear in many other parts of the globe-some 97%-98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%-3% of national health budgets is for preventive medicine, even less than that proportion is specifically allocated for cancer prevention. When the money for 'curing and caring' for the diseased populace runs short, there is likely not much left for partly controversial disease prevention in the (still) healthy part of the population.

Hardcover. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Hardcover. Condición: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Hardcover. Condición: Brand New. 1st edition. 251 pages. 9.25x6.00x0.50 inches. In Stock.

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on 'Primary Therapy of Early Breast Cancer' as well as 'Supportive Care in Cancer' for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today's medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland-and we fear in many other parts of the globe-some 97%-98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%-3% of national health budgets is for preventive medicine, even less than that proportion is specifically allocated for cancer prevention. When the money for 'curing and caring' for the diseased populace runs short, there is likely not much left for partly controversial disease prevention in the (still) healthy part of the population. 272 pp. Englisch.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored.

Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on ¿Primary Therapy of Early Breast Cancer¿ as well as ¿Supportive Care in Cancer¿ for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more recent and not yet generally accepted and w- comed concept in modern oncology. Since today¿s medical expenses are soaring and me- cal research budgets are stagnating or even being cut, neither politicians nor industry is willing to risk an additional unpredictable channel of expenses, such as that demanded by clinical cancer prevention efforts! In Switzerland¿and we fear in many other parts of the globe¿some 97%¿98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%¿3% of national health budgets is for preventive medicine, even less than that proportion is specifically allocated for cancer prevention. When the money for ¿curing and caring¿ for the diseased populace runs short, there is likely not much left for partly controversial disease prevention in the (still) healthy part of the population.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 272 pp. Englisch.